Guggenheim reiterates Buy on AbbVie, $288 price target
Guggenheim reiterated a Buy rating on AbbVie and set a $288.00 price target.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.